Summit Therapeutics Inc (SMMT)

Feb 21, 2025

(SMMT) Investment Report - Stock Traders Daily

Feb 21, 2025

Feb 20, 2025

Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Summit Therapeutics (SMMT) to Release Quarterly Earnings on Tuesday - MarketBeat

Feb 20, 2025

Feb 18, 2025

Summit Therapeutics Earnings: Critical Q4 Financial Report & Strategic Roadmap Reveal Coming February 24 - StockTitan

Feb 18, 2025

Feb 18, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 6.8%Time to Sell? - MarketBeat

Feb 18, 2025

Feb 17, 2025

3 Stocks That Could Trounce the Market in 2025 - Yahoo Finance

Feb 17, 2025

Feb 15, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Down 6.8%Here's What Happened - MarketBeat

Feb 15, 2025

Feb 15, 2025

Summit Therapeutics (SMMT) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 15, 2025

Feb 14, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Feb 14, 2025

Feb 13, 2025

U.S. investors, Big Pharma race to find new medicines in China - CNBC

Feb 13, 2025

Feb 13, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Up 6%Here's Why - MarketBeat

Feb 13, 2025

Feb 11, 2025

SG Americas Securities LLC Sells 19,587 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 11, 2025

Feb 11, 2025

When the Price of (SMMT) Talks, People Listen - Stock Traders Daily

Feb 11, 2025

Feb 10, 2025

abrdn plc Increases Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 10, 2025

Feb 10, 2025

Mid-Cap Biopharma’s Biggest Winners And Losers Of 2024 - Citeline News & Insights

Feb 10, 2025

Feb 09, 2025

Calamos Advisors LLC Has $425,000 Position in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 09, 2025

Feb 09, 2025

Is Summit Therapeutics a Millionaire Maker? - Nasdaq

Feb 09, 2025

Feb 08, 2025

2 Stocks That Could Soar Again in 2025 - MSN

Feb 08, 2025

Feb 08, 2025

Why Summit Therapeutics Inc. (SMMT) Is Among the Best Healthcare Stocks To Buy According to Analysts - Insider Monkey

Feb 08, 2025

Feb 07, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 5.4%Should You Sell? - MarketBeat

Feb 07, 2025

Feb 07, 2025

The drug industry is having its own DeepSeek moment | Mint - Mint

Feb 07, 2025

Feb 07, 2025

The Drug Industry Is Having Its Own DeepSeek Moment - The Wall Street Journal

Feb 07, 2025

Feb 06, 2025

China Universal Asset Management Co. Ltd. Acquires 17,014 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 06, 2025

Feb 05, 2025

Summit Therapeutics Inc. (NASDAQ:SMMT) Receives $33.57 Average Price Target from Brokerages - MarketBeat

Feb 05, 2025

Feb 04, 2025

Five Pine Wealth Management Makes New Investment in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 04, 2025

Feb 03, 2025

Summit Therapeutics (SMMT): Jim Cramer Calls It a ‘Very Big Spec’ - Insider Monkey

Feb 03, 2025

Feb 03, 2025

Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There' - Benzinga India

Feb 03, 2025

Feb 02, 2025

Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 02, 2025

Feb 01, 2025

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? - MSN

Feb 01, 2025

Feb 01, 2025

Griffin Asset Management Inc. Purchases 42,900 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Feb 01, 2025

Jan 31, 2025

Lightning Round: I don't want to sell Adobe down here, says Jim Cramer - MSN

Jan 31, 2025

Jan 29, 2025

Is Summit Therapeutics Inc. (SMMT) the Unstoppable Stock to Buy in 2025? - Yahoo Finance

Jan 29, 2025